BioVoice News March2023 | Page 21

In her pursuit of a smart digital tool for early stage breast cancer diagnosis , Dr Geetha Manjunath created a solution that every woman in India must be highly proud of . The core technology of her solution is an artificial intelligence led diagnostic platform that uses patented thermal image processing and machine learning algorithms for reliable and accurate breast cancer screening .

A computer scientist , Dr Manjunath is the founder and CEO of NIRAMAI Health Analytix , a Bengaluru based startup where she has developed a breakthrough AI solution , Thermalytix to detect cancer in a non-invasive radiation-free manner . She comes with over 25 years of experience in IT innovation , having led multiple AI projects at Xerox Research and Hewlett Packard India . Before starting NIRAMAI , Geetha was a Lab Director for Data Analytics Research at Xerox India .
In 2009 , Dr Manjunath was named as one of the top 50 NASSCOM IT Innovators . She holds a PhD from Indian Institute of Science , Bengaluru and management education from Kellogg ’ s Chicago . She has received numerous international and national recognition for her innovations and entrepreneurial work , including CSI Gold Medal , BIRAC WinER Award 2018 and is also on the Forbes List of Top 20 Self-Made Women 2020 . She was recently awarded the Accenture Vahini Innovator of the Year Award from Economic
Times . She is also an inventor of 16 US patents and more pending grants .
The product , Thermalytix , is radiation-free , portable , automated , affordable and thus can be conducted at hospitals or rural areas . The product is significant because of the fact that there is no test for screening women under 45 years of age , especially when almost 50 % of the ladies detected with breast cancer are under 45 . Privacy of patients is of utmost importance and unlike mammography , Niramai ' s imaging method is non-touch , not painful . The test has been installed in over 150 + hospitals and diagnostic centres in 30 Indian cities . The customers include Apollo Clinics , HCG , Narayana Health , Rainbow Hospitals among others . Niramai test is also available in the United Arab Emirates , Kenya , Sweden , Turkey , and Philippines through distributors .
Current Position : CEO and CTO , NIRAMAI Health Analytix
Impact : A breakthrough AI solution for detecting early stage breast cancer in a noninvasive radiation-free manner
Notable Awards : CSI Gold Medal ; BIRAC WinER Award 2018 ; Forbes List of Top 20 ; Self-Made Women 2020 ; ET Accenture Vahini Innovator of the Year Award
Alma Mater : Indian Institute of Science , Bengaluru ; Kellogg ’ s Chicago
With a vision to create a cancer-free world , Dr Manjunath feels that AI has the potential to revolutionize healthcare delivery . “ We realized early on how comfortable women were with our solution . Since the screening test was completely privacy aware and radiation free , women were very open to take the test . We also fine-tuned the algorithms , did multiple clinical trials and got good results to drive clinical and regulatory acceptance . We find doctors being more open to accept AI based products as their tools now . It is an exciting time for people working in AI for healthcare .”

HealthTech

BIOVOICENEWS . COM 21